⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 26, 2024JAMAOpen Access

Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines

Niklas Worm Andersson Emilia Myrup Thiesson Anders Hviid

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study examines the association between XBB.1.5-containing vaccines administered as a fifth COVID-19 vaccine dose and the risk of 28 adverse events.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Andersson et al. (2024) studied this question.

synapsesocial.com/papers/68e777b3b6db6435876ecc63 https://doi.org/10.1001/jama.2024.1036

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series studycase_series · 2025 · 9 citations
2XBB.1.5 mRNA COVID-19 Vaccination and Inpatient or Emergency Department Visits Among Adults Infected with SARS-CoV-2 JN.1 and XBB-Lineage Variants2024 · 3 citations
3Comparative effectiveness of the monovalent XBB.1.5-containing covid-19 mRNA vaccine across three Nordic countries2024 · 5 citations
4Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis2024 · 5 citations
5XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.12024 · 166 citations